Revolution Medicines, Inc. (RVMD)
151.07
+3.86
(+2.62%)
USD |
NASDAQ |
May 06, 16:00
150.59
-0.48
(-0.32%)
After-Hours: 06:07
Revolution Medicines Cash from Investing (Quarterly) : 74.88M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -135.72M |
| AtriCure, Inc. | -3.852M |
| Eli Lilly & Co. | -3.916B |
| Travere Therapeutics, Inc. | 21.55M |
| Kymera Therapeutics, Inc. | -142.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -274.24M |
| Cash from Financing (Quarterly) | 365.66M |
| Free Cash Flow | -913.73M |
| Free Cash Flow Per Share (Quarterly) | -1.404 |
| Free Cash Flow to Equity (Quarterly) | -544.85M |
| Free Cash Flow to Firm (Quarterly) | -264.23M |
| Free Cash Flow Yield | -3.17% |